Standard BioTools (FLDM) Stock Analysis

What Standard BioTools does

Standard BioTools Inc. is a global enterprise dedicated to the development, production, and distribution of sophisticated instruments, expendable supplies, specialized chemical reagents, and software solutions for both scientific research and clinical diagnostic laboratories worldwide. The company's comprehensive product lineup features advanced analytical platforms such as the Helios CyTOF system, alongside Hyperion imaging systems, Hyperion tissue imagers, and flow conductors. To support biological investigations, they provide a range of assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits, particularly valuable in immuno-oncology research. Their offerings also encompass preparatory instrumentation like the Juno systems, as well as high-performance analytical systems such as the Biomark HD system and EP1 system. A core element of their technology involves integrated fluidic circuits (IFCs), available in multiple configurations including library preparation IFCs, Juno genotyping IFCs, dynamic array IFCs, digital array IFCs, and Flex Six IFCs. Complementing these, they offer an extensive array of assays and reagents, spanning Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers, targeted sequencing prep primers, and targeted DNA Seq library assays. Furthermore, Standard BioTools specializes in single-cell microfluidics with its C1 systems and corresponding C1 IFCs, augmented by various software solutions. Their diverse customer base includes academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical and biotechnology companies, plant and animal research organizations, and contract research organizations. The company holds significant license agreements with esteemed institutions such as the California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. Established in 1999 under its initial name, Mycometrix Corporation, the firm rebranded to Fluidigm Corporation in April 2001 and maintains its headquarters in South San Francisco, California.

Key metrics

ETFs linked to FLDM

Broad-market and Healthcare sector ETFs an investor holding Standard BioTools is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how FLDM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Standard BioTools?

Standard BioTools trades under the ticker FLDM on NASDAQ.

Which exchange is FLDM listed on?

FLDM is listed on NASDAQ.

What sector does Standard BioTools operate in?

Standard BioTools is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze FLDM in a portfolio?

PortView shows FLDM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.